<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.3 20210610//EN" "JATS-journalpublishing1-3.dtd">
<article article-type="research-article" dtd-version="1.3" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xml:lang="ru"><front><journal-meta><journal-id journal-id-type="publisher-id">ymj</journal-id><journal-title-group><journal-title xml:lang="ru">Якутский медицинский журнал</journal-title><trans-title-group xml:lang="en"><trans-title>Yakut Medical Journal</trans-title></trans-title-group></journal-title-group><issn pub-type="ppub">1813-1905</issn><issn pub-type="epub">2312-1017</issn><publisher><publisher-name>ЯНЦ КМП</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="doi">10.25789/YMJ.2020.70.20</article-id><article-id custom-type="elpub" pub-id-type="custom">ymj-689</article-id><article-categories><subj-group subj-group-type="heading"><subject>Research Article</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="ru"><subject>АРКТИЧЕСКАЯ МЕДИЦИНА</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="en"><subject>ARCTIC MEDICINE</subject></subj-group></article-categories><title-group><article-title>Ассоциация полиморфизма гена IL-6 с артериальной гипертензией и ее факторами риска у коренных малочисленных народов Якутии</article-title><trans-title-group xml:lang="en"><trans-title>Association of IL-6 gene polymorphism with arterial hypertension and its risk factors in indigenous peoples of Yakutia</trans-title></trans-title-group></title-group><contrib-group><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0003-0010-9850</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Софронова</surname><given-names>С. И.</given-names></name><name name-style="western" xml:lang="en"><surname>Sofronova</surname><given-names>S. I.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Софронова Саргылана Ивановна – к.м.н., гл.н.с.-руковод. Отдела</p></bio><bio xml:lang="en"><p>Sofronova Sargylana Ivanovna – PHD, researcher</p><p>89841094825</p><p>677000, The Republic of Sakha (Yakutia),Yakutsk, Sergelyakhskoe shosse, 4</p></bio><email xlink:type="simple">sara2208@mail.ru</email><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0002-4817-5315</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Романова</surname><given-names>А. Н.</given-names></name><name name-style="western" xml:lang="en"><surname>Romanova</surname><given-names>A. N.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Романова Анна Николаевна – д.м.н., директор</p></bio><bio xml:lang="en"><p>Romanova Anna Nikolaevna – MD, director</p><p>8(4112)32-19-81</p><p>677000, The Republic of Sakha (Yakutia),Yakutsk, Sergelyakhskoe shosse, 4</p></bio><email xlink:type="simple">ranik@mail.ru</email><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Кириллина</surname><given-names>М. П.</given-names></name><name name-style="western" xml:lang="en"><surname>Kirillina</surname><given-names>M. P.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Кириллина Мария Петровна – к.б.н., в.н.с.-руковод. лаб., зав. лаб. Клиники</p></bio><bio xml:lang="en"><p>Kirillina Marya Petrovna – PHD, researcher</p><p>677000, The Republic of Sakha (Yakutia),Yakutsk, Sergelyakhskoe shosse, 4</p></bio><email xlink:type="simple">kirillinamp@mail.ru</email><xref ref-type="aff" rid="aff-2"/></contrib></contrib-group><aff-alternatives id="aff-1"><aff xml:lang="ru">ЯНЦ КМП<country>Россия</country></aff><aff xml:lang="en">Yakut science centre of complex medical problems<country>Russian Federation</country></aff></aff-alternatives><aff-alternatives id="aff-2"><aff xml:lang="ru">МИ СВФУ им. М.К. Аммосова<country>Россия</country></aff><aff xml:lang="en">Yakut science centre of complex medical problems<country>Russian Federation</country></aff></aff-alternatives><pub-date pub-type="collection"><year>2020</year></pub-date><pub-date pub-type="epub"><day>17</day><month>05</month><year>2025</year></pub-date><volume>0</volume><issue>2</issue><fpage>65</fpage><lpage>68</lpage><permissions><copyright-statement>Copyright &amp;#x00A9; Софронова С.И., Романова А.Н., Кириллина М.П., 2025</copyright-statement><copyright-year>2025</copyright-year><copyright-holder xml:lang="ru">Софронова С.И., Романова А.Н., Кириллина М.П.</copyright-holder><copyright-holder xml:lang="en">Sofronova S.I., Romanova A.N., Kirillina M.P.</copyright-holder><license license-type="creative-commons-attribution" xlink:href="https://creativecommons.org/licenses/by/4.0/" xlink:type="simple"><license-p>This work is licensed under a Creative Commons Attribution 4.0 License.</license-p></license></permissions><self-uri xlink:href="https://ymj.elpub.ru/jour/article/view/689">https://ymj.elpub.ru/jour/article/view/689</self-uri><abstract><p>Для определения ассоциации полиморфизма гена IL-6 с артериальной гипертензией (АГ) и факторами риска проведено исследование «случай-контроль» в селах Колымское и Андрюшкино Нижнеколымского района Якутии. Выявлена взаимосвязь с АГ и ее факторами риска полиморфизма гена IL-6, а именно определено влияние G аллеля полиморфного локуса C-174G и C аллеля полиморфного локуса C-572G на метаболические факторы атерогенеза. У гипертоников-носителей аллеля G полиморфного локуса C-174G гена IL-6 как в гомозиготном, так и в гетерозиготном варианте отмечены наиболее высокое среднее систолическое АД, высокая частота абдоминального ожирения, нарушений липидного и углеводного обменов. Исследование полиморфного локуса C-572G гена IL-6 у лиц с АГ показало наиболее высокую частоту абдоминального ожирения, нарушений липидного и углеводного обменов у носителей C аллеля.</p></abstract><trans-abstract xml:lang="en"><p>A case-control study was conducted in Kolymskoye and Andryushkino of Nizhnekolymsky district of Yakutia to determine the association of IL-6 gene polymorphism with arterial hypertension (AH) and risk factors. The relationship with AH and its risk factors for IL-6 gene polymorphism was obtained, namely, the influence of the G allele of the polymorphic locus C-174G and the C allele of the polymorphic locus C-572G on metabolic factors of atherogenesis. Hypertensive patients - carriers of the G allele of the C-174G polymorphic locus of the IL-6 gene, both in the homozygous and heterozygous versions, showed the highest average systolic blood pressure, a high incidence of abdominal obesity, lipid and carbohydrate metabolism disorders. The study of the polymorphic locus C-572G of the IL-6 gene in patients with hypertension showed the highest incidence of abdominal obesity, lipid and carbohydrate metabolism disorders in carriers of the C allele.</p></trans-abstract><kwd-group xml:lang="ru"><kwd>ген IL-6</kwd><kwd>локус C-174G</kwd><kwd>C-572G</kwd><kwd>артериальная гипертензия</kwd><kwd>факторы риска</kwd><kwd>коренные малочисленные народы</kwd><kwd>Якутия</kwd></kwd-group><kwd-group xml:lang="en"><kwd>gene IL-6</kwd><kwd>locus C-174G</kwd><kwd>C-572G</kwd><kwd>arterial hypertension</kwd><kwd>risk factors</kwd><kwd>indigenous people</kwd><kwd>Yakutia</kwd></kwd-group></article-meta></front><back><ref-list><title>References</title><ref id="cit1"><label>1</label><citation-alternatives><mixed-citation xml:lang="ru">Российский статистический ежегодник. – М., 2018. - 694 с.</mixed-citation><mixed-citation xml:lang="en">РRussian Statistical Yearbook. – 2018. – 694 p.</mixed-citation></citation-alternatives></ref><ref id="cit2"><label>2</label><citation-alternatives><mixed-citation xml:lang="ru">Ahn S.Y. Genetic programming of hypertension / S.Y. Ahn, C. Gupta // Front Pediatr. – 2018. – № 5. – 285 p. doi: 10.3389/fped.2017.00285</mixed-citation><mixed-citation xml:lang="en">Ahn S.Y. Genetic programming of hypertension / S.Y. Ahn, C. Gupta // Front Pediatr. – 2018. – № 5. – 285 p. doi: 10.3389/fped.2017.00285</mixed-citation></citation-alternatives></ref><ref id="cit3"><label>3</label><citation-alternatives><mixed-citation xml:lang="ru">Association of interleukin-6 gene polymorphism with coronary artery disease: an updated systematic review and cumulative meta-analysis / H. Hou, C. Wang, F. Sun [et al.] // Inflamm Res. – 2015. – № 64(9). – 707-720 p.</mixed-citation><mixed-citation xml:lang="en">Association of interleukin-6 gene polymorphism with coronary artery disease: an updated systematic review and cumulative meta-analysis / H. Hou, C. Wang, F. Sun [et al.] // Inflamm Res. – 2015. – № 64(9). – 707-720 p.</mixed-citation></citation-alternatives></ref><ref id="cit4"><label>4</label><citation-alternatives><mixed-citation xml:lang="ru">Association of IL-6 Polymorphism –174G/C and Metabolic Syndrome in Hypertensive Patients / Andrei Alkmim Teixeira, Beata Marie Redublo Quinto, Maria Aparecida Dalboni [et al.] // BioMed Research International. – 2015. – 6 p. https://doi.org/10.1155/2015/927589</mixed-citation><mixed-citation xml:lang="en">Association of IL-6 Polymorphism –174G/C and Metabolic Syndrome in Hypertensive Patients / Andrei Alkmim Teixeira, Beata Marie Redublo Quinto, Maria Aparecida Dalboni [et al.] // BioMed Research International. – 2015. – 6 p. https://doi.org/10.1155/2015/927589</mixed-citation></citation-alternatives></ref><ref id="cit5"><label>5</label><citation-alternatives><mixed-citation xml:lang="ru">BMI modifies associations of IL-6 genotypes with insulin resistance: the Framingham study / A. Herbert, C. Liu, S. Karamohamed [et al.] // Obesity. – 2006. - №8(14). – P. 1454-1461. DOI: 10.1038/oby.2006.165</mixed-citation><mixed-citation xml:lang="en">BMI modifies associations of IL-6 genotypes with insulin resistance: the Framingham study / A. Herbert, C. Liu, S. Karamohamed [et al.] // Obesity. – 2006. - №8(14). – P. 1454-1461. DOI: 10.1038/oby.2006.165</mixed-citation></citation-alternatives></ref><ref id="cit6"><label>6</label><citation-alternatives><mixed-citation xml:lang="ru">Global burden of hypertension and systolic blood pressure of at least 110 to 115 mm Hg, 1990-2015 / M. Forouzanfar, P. Liu, G. Roth [et al.] // JAMA. – 2017. – № 317(2). – P. 165-182. https://doi.org/10.1001/jama.2016.19043</mixed-citation><mixed-citation xml:lang="en">Global burden of hypertension and systolic blood pressure of at least 110 to 115 mm Hg, 1990-2015 / M. Forouzanfar, P. Liu, G. Roth [et al.] // JAMA. – 2017. – № 317(2). – P. 165-182. https://doi.org/10.1001/jama.2016.19043</mixed-citation></citation-alternatives></ref><ref id="cit7"><label>7</label><citation-alternatives><mixed-citation xml:lang="ru">Guideline for the Prevention, Detection, Evaluation, and Management of High Blood Pressure in Adults: A Report of the American College of Cardiology. American Heart Association Task Force on Clinical Practice Guidelines / P.K. Whelton, R.M. Carey, W.S. Aronow [et al.] // J Am Coll Cardiol. – 2018. - №71 (19). – P. e127-e248. doi: 10.1016/j.jacc.2017.11.006.</mixed-citation><mixed-citation xml:lang="en">Guideline for the Prevention, Detection, Evaluation, and Management of High Blood Pressure in Adults: A Report of the American College of Cardiology. American Heart Association Task Force on Clinical Practice Guidelines / P.K. Whelton, R.M. Carey, W.S. Aronow [et al.] // J Am Coll Cardiol. – 2018. - №71 (19). – P. e127-e248. doi: 10.1016/j.jacc.2017.11.006.</mixed-citation></citation-alternatives></ref><ref id="cit8"><label>8</label><citation-alternatives><mixed-citation xml:lang="ru">Harrison DG. The immune system in hypertension / D.G. Harrison // AJP Advances in Physiology Education. – 2014. – №38 (1). – P. 20-4. DOI: 10.1152/advan.00063.2013</mixed-citation><mixed-citation xml:lang="en">Harrison DG. The immune system in hypertension / D.G. Harrison // AJP Advances in Physiology Education. – 2014. – №38 (1). – P. 20-4. DOI: 10.1152/advan.00063.2013</mixed-citation></citation-alternatives></ref><ref id="cit9"><label>9</label><citation-alternatives><mixed-citation xml:lang="ru">Interleukin-6 in cardiovascular disorders / Anna Dobrucka-Głowacka, Beata Sarecka-Hujar, Dorota Raczkiewicz [et al.] // European Journal of Medical Technologies. – 2018. – №3 (20). – P. 23-30.</mixed-citation><mixed-citation xml:lang="en">Interleukin-6 in cardiovascular disorders / Anna Dobrucka-Głowacka, Beata Sarecka-Hujar, Dorota Raczkiewicz [et al.] // European Journal of Medical Technologies. – 2018. – №3 (20). – P. 23-30.</mixed-citation></citation-alternatives></ref><ref id="cit10"><label>10</label><citation-alternatives><mixed-citation xml:lang="ru">Interleukin-6 promoter polymorphism and cardiovascular risk factors: the Health 2000 Survey / A. Riikola [et al.] // Atherosclerosis.- 2009. -Vol.207 (2). – P. 466-470.</mixed-citation><mixed-citation xml:lang="en">Interleukin-6 promoter polymorphism and cardiovascular risk factors: the Health 2000 Survey / A. Riikola [et al.] // Atherosclerosis.- 2009. -Vol.207 (2). – P. 466-470.</mixed-citation></citation-alternatives></ref><ref id="cit11"><label>11</label><citation-alternatives><mixed-citation xml:lang="ru">McMaster W.G. Inflammation, immunity, and hypertensive end-organ damage / W.G. McMaster, A. Kirabo, M.S. Madhur, D.G. Harrison // Circ Res.– 2015. – №116 (6). – P.1022-33.</mixed-citation><mixed-citation xml:lang="en">McMaster W.G. Inflammation, immunity, and hypertensive end-organ damage / W.G. McMaster, A. Kirabo, M.S. Madhur, D.G. Harrison // Circ Res.– 2015. – №116 (6). – P.1022-33.</mixed-citation></citation-alternatives></ref><ref id="cit12"><label>12</label><citation-alternatives><mixed-citation xml:lang="ru">Polymorphism in the IL6 promoter region is associated with the risk factors and markers of subclinical atherosclerosis in men: the Cardiovascular Risk in Young Finns Study / J. Hulkkonen, T. Lehtimäki, N. Mononen [et al.] // Atherosclerosis. – 2009. – №203 (2). – P. 454-458. DOI: 10.1016/j.atherosclerosis.2008.07.014</mixed-citation><mixed-citation xml:lang="en">Polymorphism in the IL6 promoter region is associated with the risk factors and markers of subclinical atherosclerosis in men: the Cardiovascular Risk in Young Finns Study / J. Hulkkonen, T. Lehtimäki, N. Mononen [et al.] // Atherosclerosis. – 2009. – №203 (2). – P. 454-458. DOI: 10.1016/j.atherosclerosis.2008.07.014</mixed-citation></citation-alternatives></ref><ref id="cit13"><label>13</label><citation-alternatives><mixed-citation xml:lang="ru">Singh M.V. The immune system and hypertension / M.V. Singh, M.W. Chapleau, S.C. Harwani, F.M. Abboud // Immunol Res.- 2014. - №59(1-3). –P. 243-53.</mixed-citation><mixed-citation xml:lang="en">Singh M.V. The immune system and hypertension / M.V. Singh, M.W. Chapleau, S.C. Harwani, F.M. Abboud // Immunol Res.- 2014. - №59(1-3). –P. 243-53.</mixed-citation></citation-alternatives></ref><ref id="cit14"><label>14</label><citation-alternatives><mixed-citation xml:lang="ru">The interleukin-6 -174 G/C promoter polymorphism is associated with risk of coronary heart disease and systolic blood pressure in healthy men / S.E. Humphries, L.A. Luong, M.S. Ogg [et al.] // European Heart Journal. – 2001. – №22(24). – P. 2243-52. doi:10.1053/euhj.2001.2678</mixed-citation><mixed-citation xml:lang="en">The interleukin-6 -174 G/C promoter polymorphism is associated with risk of coronary heart disease and systolic blood pressure in healthy men / S.E. Humphries, L.A. Luong, M.S. Ogg [et al.] // European Heart Journal. – 2001. – №22(24). – P. 2243-52. doi:10.1053/euhj.2001.2678</mixed-citation></citation-alternatives></ref><ref id="cit15"><label>15</label><citation-alternatives><mixed-citation xml:lang="ru">Yang X. Association of IL-6 −174G&gt;C and −572C&gt;G polymorphisms with risk of young ischemic stroke patients / X. Yang, L. Feng, C. Li, Y. Li // Gene. – 2014. - №539. – P. 258-262.</mixed-citation><mixed-citation xml:lang="en">Yang X. Association of IL-6 −174G&gt;C and −572C&gt;G polymorphisms with risk of young ischemic stroke patients / X. Yang, L. Feng, C. Li, Y. Li // Gene. – 2014. - №539. – P. 258-262.</mixed-citation></citation-alternatives></ref></ref-list><fn-group><fn fn-type="conflict"><p>The authors declare that there are no conflicts of interest present.</p></fn></fn-group></back></article>
